tiprankstipranks
Trending News
More News >
Cts Corp. (CTS)
NYSE:CTS

CTS (CTS) AI Stock Analysis

Compare
121 Followers

Top Page

CT

CTS

(NYSE:CTS)

Rating:73Outperform
Price Target:
$46.00
▲( 12.20% Upside)
CTS's overall score reflects a solid financial foundation with strong operational efficiency and a stable outlook from technical indicators. The company's strategic diversification and growth initiatives are positive, but revenue stagnation and external challenges weigh on the score.

CTS (CTS) vs. SPDR S&P 500 ETF (SPY)

CTS Business Overview & Revenue Model

Company DescriptionCTS Corporation manufactures and sells sensors, actuators, and connectivity components in North America, Europe, and Asia. The company provides sensors and actuators for use in passenger or commercial vehicles; connectivity components for telecommunications infrastructure, information technology, and other high-speed applications; switches, temperature sensors, and potentiometers supplied to multiple markets; and fabricated piezoelectric materials and substrates used primarily in medical, industrial, aerospace and defense, and information technology markets. In addition, the company sells and markets its products through its sales engineers, independent manufacturers' representatives, and distributors. CTS Corporation was founded in 1896 and is headquartered in Lisle, Illinois.
How the Company Makes MoneyCTS generates revenue through the sale of its sensors, actuators, and electronic components to a wide range of industries. The company's key revenue streams include direct sales to original equipment manufacturers (OEMs) in the automotive and industrial sectors, as well as contracts with medical and communications companies. CTS also engages in strategic partnerships and collaborations to expand its market reach and drive innovation. The company's earnings are significantly influenced by its ability to adapt to technological advancements and meet the specific needs of its clients, ensuring a steady demand for its products.

CTS Financial Statement Overview

Summary
CTS demonstrates a robust financial position with solid profitability and cash flow metrics. While revenue growth has faced challenges, the company maintains strong operational margins and a healthy balance sheet. Continued focus on revenue expansion and managing cash flow volatility will be key to sustaining financial performance.
Income Statement
75
Positive
The income statement of CTS depicts a stable gross profit margin and improving net income over the TTM period. However, there is a noticeable decline in total revenue compared to previous years, indicating potential challenges in revenue growth. Despite this, the company maintains decent EBIT and EBITDA margins, showcasing operational efficiency.
Balance Sheet
80
Positive
CTS exhibits a strong balance sheet with a high equity ratio and manageable debt levels, reflected in a moderate debt-to-equity ratio. The company has a solid return on equity, indicating effective utilization of shareholder funds. However, fluctuations in total assets and equity warrant close monitoring.
Cash Flow
78
Positive
The cash flow statement indicates a healthy operating cash flow with a consistent free cash flow generation over the years. The free cash flow to net income ratio is strong, suggesting efficient cash conversion from earnings. However, investing and financing cash flows show volatility, which could impact future liquidity.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
515.72M515.77M550.42M586.87M512.92M424.07M
Gross Profit
190.92M189.15M190.86M210.54M184.62M139.06M
EBIT
76.03M72.78M75.05M55.09M78.17M23.91M
EBITDA
93.88M108.17M107.19M113.22M-32.58M71.98M
Net Income Common Stockholders
60.36M58.11M60.53M59.58M-41.87M34.69M
Balance SheetCash, Cash Equivalents and Short-Term Investments
90.29M94.33M163.88M156.91M141.47M91.77M
Total Assets
765.53M766.11M741.17M748.49M664.46M626.05M
Total Debt
112.20M117.09M96.86M109.36M74.75M81.06M
Net Debt
21.91M22.76M-67.02M-47.55M-66.72M-10.72M
Total Liabilities
227.29M235.26M214.34M242.26M200.88M202.37M
Stockholders Equity
538.24M530.85M526.82M506.22M463.58M423.68M
Cash FlowFree Cash Flow
77.42M80.64M74.07M106.86M70.50M61.92M
Operating Cash Flow
96.50M99.29M88.81M121.20M86.14M76.78M
Investing Cash Flow
-140.99M-140.56M-18.10M-111.19M-15.90M-23.17M
Financing Cash Flow
-27.53M-27.93M-65.40M4.34M-20.71M-61.33M

CTS Technical Analysis

Technical Analysis Sentiment
Negative
Last Price41.00
Price Trends
50DMA
40.29
Positive
100DMA
44.36
Negative
200DMA
47.24
Negative
Market Momentum
MACD
0.73
Negative
RSI
50.97
Neutral
STOCH
59.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTS, the sentiment is Negative. The current price of 41 is above the 20-day moving average (MA) of 40.71, above the 50-day MA of 40.29, and below the 200-day MA of 47.24, indicating a neutral trend. The MACD of 0.73 indicates Negative momentum. The RSI at 50.97 is Neutral, neither overbought nor oversold. The STOCH value of 59.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CTS.

CTS Risk Analysis

CTS disclosed 38 risk factors in its most recent earnings report. CTS reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
As we integrate artificial intelligence technologies into our processes, these technologies may present business, compliance and reputational risks. Q4, 2024
2.
A portion of our revenue is derived from the sale of defense-related products through various contracts and subcontracts. These contracts may be suspended, canceled, or delayed, which could have an adverse impact on our revenues. Q4, 2024
3.
Uncertainty over global tariffs and trade policies, or the financial impact of tariffs and trade policies, may negatively affect our results. Q4, 2024

CTS Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$2.98B38.605.02%11.65%
CTCTS
73
Outperform
$1.26B21.3211.39%0.38%-2.76%16.64%
BHBHE
68
Neutral
$1.34B25.654.84%1.82%-7.36%-20.46%
65
Neutral
$1.97B81.144.16%-14.92%-91.72%
ROROG
64
Neutral
$1.27B73.361.34%-8.06%-75.10%
60
Neutral
$11.56B10.24-7.04%2.94%7.46%-10.54%
51
Neutral
$626.60M-89.38%0.55%11.68%-26360.70%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CTS
CTS
41.00
-11.13
-21.35%
BHE
Benchmark Electronics
36.39
-5.95
-14.05%
MLAB
Mesa Laboratories
111.97
-0.24
-0.21%
ROG
Rogers
66.63
-50.47
-43.10%
TTMI
TTM Technologies
28.90
10.32
55.54%
VICR
Vicor
41.47
6.71
19.30%

CTS Earnings Call Summary

Earnings Call Date:Apr 30, 2025
(Q1-2025)
|
% Change Since: 2.78%|
Next Earnings Date:Jul 29, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed outlook. While there was significant growth in diversified markets and strong performance in medical, aerospace, and defense sectors, overall sales remained flat with notable declines in transportation sales. Challenges due to tariffs and geopolitical uncertainties contribute to a cautious outlook for the second half of the year.
Q1-2025 Updates
Positive Updates
Diversified Markets Growth
Revenue from diversified markets grew 14% in the quarter, with strong bookings and a book-to-bill ratio of 1.28.
Medical End Market Performance
First quarter sales in the medical end market were up 13% compared to the same period in 2024, with a book-to-bill ratio of 1.3.
Aerospace and Defense Sales Increase
Sales for the aerospace and defense market were up 39% from the first quarter of 2024, with bookings up 32%.
Industrial Market Recovery
Sales in the industrial market were up 4% year-over-year, with bookings up 19% from the same period last year.
Strong Cash Position
The company generated $16 million in operating cash flow and maintained a cash balance of $90 million at the end of the quarter.
SyQwest Acquisition
The acquisition added $3 million in revenue during the quarter and is expected to contribute to stronger sales in the second half of 2025.
Negative Updates
Flat Overall Sales
First quarter sales were $126 million, essentially flat from the first quarter of 2024.
Transportation Sales Decline
Transportation sales were down approximately 12% due to China market dynamics and competition for commercial vehicle products.
Impact of Tariffs and Geopolitical Uncertainty
The company faces uncertainty due to tariffs and geopolitical factors, impacting transportation markets and creating potential headwinds.
Earnings Decline
Adjusted earnings for the first quarter were $0.44 per diluted share, compared to $0.47 per diluted share for the same period last year.
Commercial Vehicle Revenue Softness
Anticipated softness in commercial vehicle revenue throughout 2025, with OEMs delaying sourcing decisions.
Company Guidance
During the first quarter of the fiscal year 2025, CTS Corporation maintained its guidance for annual sales between $520 million and $550 million and adjusted diluted earnings per share (EPS) ranging from $2.20 to $2.35. The company reported first-quarter sales of $126 million, consistent with the previous year, and a 14% increase in diversified end market sales. The book-to-bill ratio for these markets improved to 1.28, indicating strong bookings. Transportation sales declined by 12% due to challenges in the Chinese market and commercial vehicle competition. Despite these challenges, CTS added new product wins and emphasized its strategic focus on diversification, particularly in medical, aerospace, and defense sectors, while cautiously monitoring second-half demand amidst geopolitical and tariff uncertainties.

CTS Corporate Events

Executive/Board ChangesShareholder Meetings
CTS Shareholders Approve Key Proposals at Annual Meeting
Neutral
May 12, 2025

On May 8, 2025, CTS held its Annual Meeting of Shareholders where all director nominees were successfully elected, and Proposals 2 and 3 were approved. The meeting included the election of seven directors and the approval of executive compensation and the appointment of Grant Thornton, LLP as the independent registered public accounting firm for the year ending December 31, 2025.

The most recent analyst rating on (CTS) stock is a Hold with a $46.00 price target. To see the full list of analyst forecasts on CTS stock, see the CTS Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
CTS Reports Q1 2025 Financial Results
Positive
Apr 30, 2025

CTS Corporation announced its financial results for the first quarter of 2025, reporting flat sales of $126 million compared to the previous year, with a 14% increase in sales to diversified markets but a 12% decline in the transportation sector. The company achieved a net income of $13 million, up from $11 million in the first quarter of 2024, and earnings per diluted share increased to $0.44. Despite economic pressures and tariff uncertainties, CTS remains committed to revenue growth and quality of earnings through diversification and strategic acquisitions.

M&A TransactionsBusiness Operations and Strategy
CTS Corporation Highlights Strategic Growth Initiatives
Positive
Apr 30, 2025

CTS Corporation has released an investor presentation for the fiscal year ending December 31, 2025, highlighting its strategic focus on growth and diversification across various end markets. The company aims to achieve 10% organic and inorganic growth by leveraging its deep custom engineered capabilities, strong customer relationships, and a robust new product pipeline. CTS is positioned to capitalize on megatrends such as automation, healthcare innovation, and electrification, supported by a strong balance sheet and strategic M&A initiatives. The company also emphasizes its commitment to sustainability and efficiency, with a focus on enhancing its core capabilities and expanding its market presence.

Executive/Board Changes
CTS Announces Resignation of Chief Legal Officer
Neutral
Mar 10, 2025

On March 5, 2025, Scott D’Angelo, Vice President, Chief Legal and Administrative Officer and Corporate Secretary of CTS Corporation, announced his resignation effective April 4, 2025. His departure was a personal decision to pursue another opportunity and was not due to any disagreement with the company.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.